Alan J. Dalby

Keine laufenden Positionen mehr

Health Technology

Consumer Non-Durables

Profil

Alan Dalby became a Non-executive Director of Acambis on 1 May 1998.
He was an executive director of SmithKline, a predecessor company to GlaxoSmithKline plc, and retired from the role of Chairman of Reckitt Benckiser plc in 2001.
He is a director of Alteon, Inc., a US-based biotechnology company.
He is the senior independent Non-executive Director.
The Board considers Mr Dalby to be an independent Non-executive Director.
He is a member of the Audit Committee and Nominations Committee, and Chairman of the Remuneration Committee.

Ehemalige bekannte Positionen von Alan J. Dalby

Unternehmen	Position	Ende
Acambis Plc Acambis Plc BiotechnologyHealth Technology Develops biopharmaceutical products and vaccines	Direktor/Vorstandsmitglied	22.09.2008
RECKITT BENCKISER GROUP PLC	Vorsitzender	01.01.2001
Smithkline Beecham Plc Smithkline Beecham Plc Pharmaceuticals: OtherHealth Technology Develops and manufactures pharmaceutical products	Direktor/Vorstandsmitglied	-
SYNVISTA THERAPEUTICS, INC.	Direktor/Vorstandsmitglied	-

Sehen Sie sich die Erfahrung von Alan J. Dalby im Detail an

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen